Please login to the form below

Not currently logged in
Email:
Password:

Lonza appoints pharma COO

Marc Funk replaces Stephan Kutzer

Marc Funk LonzaSwiss life sciences firm Lonza has announced that Stephan Kutzer is to step down as chief operations officer for its pharma and biotech division to be replaced by Marc Funk.

Funk, who is currently the company's chief legal officer, will take over from Kutzer on July 1, 2014.

Richard Ridinger, CEO of Lonza, said: “[Funk] has already successfully managed operational and commercial projects in the pharma and biotech network and has been responsible for global quality in pharma & biotech for more than a year.”

Funk's experience prior to joining Lonza in 2008 includes four years as corporate counsel at Merck Serono.

He was also previously a co-CEO at GeneProt, a now defunct US-based biotech company.

29th April 2014

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics